Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Jan, 8 2026
Dec, 30 2025
Jan, 19 2026
Apr, 22 2026
Oct, 12 2025